AR083893A1 - Uso de una composicion farmaceutica que comprende (s) (3-(1-(1h-imidazol-4-il)etil)-2-metilfenil)metanol para preparar un medicamento topico de utilidad en la reduccion de la presion intraocular y articulo de manufactura correspondiente - Google Patents
Uso de una composicion farmaceutica que comprende (s) (3-(1-(1h-imidazol-4-il)etil)-2-metilfenil)metanol para preparar un medicamento topico de utilidad en la reduccion de la presion intraocular y articulo de manufactura correspondienteInfo
- Publication number
- AR083893A1 AR083893A1 ARP110104278A ARP110104278A AR083893A1 AR 083893 A1 AR083893 A1 AR 083893A1 AR P110104278 A ARP110104278 A AR P110104278A AR P110104278 A ARP110104278 A AR P110104278A AR 083893 A1 AR083893 A1 AR 083893A1
- Authority
- AR
- Argentina
- Prior art keywords
- intraocular pressure
- imidazol
- methanol
- prepare
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Abstract
Uso de una composición farmacéutica que comprende desde 0,01 % hasta 5% de (S) (3-(1-(1H-imidazol-4-il)etil)-2-metilfenil)metanol o una de sus sales, para preparar un medicamento tópico de utilidad en la reducción de la presión intraocular en un ojo afectado de un paciente. El medicamento es para una única dosis, una o dos veces por día, y el ojo afectado tiene una presión intraocular inferior a la presión intraocular basal durante al menos ocho (8) horas, diez (10) horas o doce (12) horas. La composición comprende además un conservante, un cosolvente y un agente de formación de viscosidad. Un artículo de manufactura que comprende un material de envase y dicho agente farmacéutico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41418010P | 2010-11-16 | 2010-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR083893A1 true AR083893A1 (es) | 2013-03-27 |
Family
ID=44999965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110104278A AR083893A1 (es) | 2010-11-16 | 2011-11-16 | Uso de una composicion farmaceutica que comprende (s) (3-(1-(1h-imidazol-4-il)etil)-2-metilfenil)metanol para preparar un medicamento topico de utilidad en la reduccion de la presion intraocular y articulo de manufactura correspondiente |
Country Status (17)
Country | Link |
---|---|
US (5) | US20120149747A1 (es) |
EP (3) | EP3093017B1 (es) |
JP (1) | JP2013542991A (es) |
KR (7) | KR102134117B1 (es) |
CN (1) | CN103298467A (es) |
AR (1) | AR083893A1 (es) |
AU (1) | AU2011329209B8 (es) |
BR (1) | BR112013012112A2 (es) |
CA (2) | CA3067290A1 (es) |
DK (1) | DK3093017T3 (es) |
ES (1) | ES2865118T3 (es) |
IL (1) | IL226384A (es) |
MX (1) | MX340859B (es) |
RU (1) | RU2013124526A (es) |
SG (3) | SG190322A1 (es) |
TW (1) | TW201304774A (es) |
WO (1) | WO2012067941A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2752148A1 (en) | 2009-02-13 | 2010-08-19 | Daniel W. Gil | Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol |
US9095576B2 (en) | 2011-11-21 | 2015-08-04 | Allergan, Inc. | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1036065B1 (en) * | 1997-12-04 | 2004-05-12 | Allergan, Inc. | Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
US20020198210A1 (en) * | 2001-05-03 | 2002-12-26 | Allergan Sales Inc. | Alpha-2-adrenergic agonist/fatty acid compositions |
US7642258B2 (en) * | 2002-04-19 | 2010-01-05 | Allergan, Inc. | Combination of brimonidine and timolol for topical ophthalmic use |
US7091232B2 (en) * | 2002-05-21 | 2006-08-15 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US20050059744A1 (en) * | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
CN1878569A (zh) * | 2003-09-12 | 2006-12-13 | 阿勒根公司 | 用于治疗疼痛和其它α2肾上腺素能介导疾病的方法及组合物 |
US20050244463A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
PL1761266T3 (pl) * | 2004-05-25 | 2013-09-30 | Galderma Pharma Sa | Związki, preparaty i sposoby leczenia lub zapobiegania procesom zapalnym skóry |
GB0611241D0 (en) * | 2006-06-07 | 2006-07-19 | Daniolabs Ltd | The treatment of increased sebum production |
GB0715790D0 (en) | 2007-08-13 | 2007-09-26 | Summit Corp Plc | Drug combination for the treatment of sialorrhoea |
WO2010014552A1 (en) * | 2008-08-01 | 2010-02-04 | Alpha Synergy Development, Inc. | Vasoconstriction compositions and methods of use |
CA2752148A1 (en) * | 2009-02-13 | 2010-08-19 | Daniel W. Gil | Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol |
-
2011
- 2011-11-10 KR KR1020207007148A patent/KR102134117B1/ko active IP Right Grant
- 2011-11-10 DK DK16176846.0T patent/DK3093017T3/da active
- 2011-11-10 SG SG2013038153A patent/SG190322A1/en unknown
- 2011-11-10 SG SG10201910521YA patent/SG10201910521YA/en unknown
- 2011-11-10 KR KR1020217019125A patent/KR20210080591A/ko not_active Application Discontinuation
- 2011-11-10 KR KR1020227040513A patent/KR20220158876A/ko not_active Application Discontinuation
- 2011-11-10 WO PCT/US2011/060236 patent/WO2012067941A1/en active Application Filing
- 2011-11-10 CA CA3067290A patent/CA3067290A1/en active Pending
- 2011-11-10 BR BR112013012112A patent/BR112013012112A2/pt not_active IP Right Cessation
- 2011-11-10 SG SG10201509423XA patent/SG10201509423XA/en unknown
- 2011-11-10 EP EP16176846.0A patent/EP3093017B1/en active Active
- 2011-11-10 KR KR1020207019691A patent/KR20200085936A/ko active Application Filing
- 2011-11-10 EP EP20200021.2A patent/EP3795154A1/en active Pending
- 2011-11-10 KR KR1020197034456A patent/KR102090441B1/ko active IP Right Grant
- 2011-11-10 MX MX2013005439A patent/MX340859B/es active IP Right Grant
- 2011-11-10 ES ES16176846T patent/ES2865118T3/es active Active
- 2011-11-10 CN CN2011800647548A patent/CN103298467A/zh active Pending
- 2011-11-10 JP JP2013539910A patent/JP2013542991A/ja active Pending
- 2011-11-10 EP EP11785262.4A patent/EP2640382B1/en active Active
- 2011-11-10 KR KR1020187023705A patent/KR102050187B1/ko active IP Right Grant
- 2011-11-10 KR KR1020137015295A patent/KR101891846B1/ko active IP Right Grant
- 2011-11-10 AU AU2011329209A patent/AU2011329209B8/en active Active
- 2011-11-10 CA CA2818144A patent/CA2818144C/en active Active
- 2011-11-10 RU RU2013124526/15A patent/RU2013124526A/ru not_active Application Discontinuation
- 2011-11-15 US US13/297,212 patent/US20120149747A1/en not_active Abandoned
- 2011-11-16 AR ARP110104278A patent/AR083893A1/es not_active Application Discontinuation
- 2011-11-16 TW TW100141941A patent/TW201304774A/zh unknown
-
2013
- 2013-05-16 IL IL226384A patent/IL226384A/en active IP Right Grant
-
2015
- 2015-11-19 US US14/945,874 patent/US20160067222A1/en not_active Abandoned
-
2017
- 2017-01-05 US US15/399,460 patent/US20170172983A1/en not_active Abandoned
-
2019
- 2019-08-07 US US16/534,712 patent/US20200206193A1/en not_active Abandoned
-
2021
- 2021-02-18 US US17/179,271 patent/US20220008393A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR084932A1 (es) | Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica | |
AR063958A1 (es) | Metodos para administrar medicaciones para la perdida de peso | |
CO6331421A2 (es) | Gel de quitosano para aplicaciones dermatologicas proceso de obtencion y uso del mismo | |
CY1119582T1 (el) | Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη | |
BR112014011841A2 (pt) | material de entrega de fármacos hidrofóbicos, método para a produção do mesmo e métodos para a entrega de uma composição de entrega de fármacos | |
EA200901112A1 (ru) | Жидкие композиции, образующие дермальные пленки, для введения лекарственных препаратов в кожу | |
PE20170302A1 (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington | |
BRPI0615860B8 (pt) | composição farmacêutica de liberação prolongada monolítica sólida | |
SV2010003451A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
BRPI0612188B8 (pt) | preparação farmacêutica para aplicação oral, método para a produção de uma preparação farmacêutica oral, preparação de comprimido para aplicação oral, método para a produção de uma preparação de comprimido | |
BR112012022797A2 (pt) | composição farmacêutica resistente a álcool, e, método para tratar uma doença com uma formulação de agente ativo resistente a álcool | |
CY1121024T1 (el) | Προ-φαρμακα εστερα της [3-(1-(1η-ιμιδαζολ-4-υλ)αιθυλ)-2-μεθυλφαινυλ] μεθανολης για μειωση ενδοοφθαλμικης πιεσης | |
BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
BRPI0411032A (pt) | composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica | |
MX2009011900A (es) | Curacion de herida diabetica. | |
BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
BR112014010467A2 (pt) | pistão para um cartucho a ser cheio com um medicamento, cartucho para ser utilizado com um dispositivo de administração de fármaco e método de fabricação de um pistão | |
BR112015026053A8 (pt) | composição farmacêutica, recipiente vedado, inalador dosimetrado, uso de um componente propelente, e, método para fabricação de uma composição farmacêutica | |
BR112022010435A2 (pt) | Camada-suporte solúvel para filme fino oral (otf) | |
ECSP10010553A (es) | Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre | |
RU2012134065A (ru) | Альфа-2 адренергический агонист, обладающий эффектом длительного снижения внутриглазного давления | |
CL2009001267A1 (es) | Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis. | |
BR112022022024A2 (pt) | Uso de um componente (i) em combinação com um componente (ii), composição farmacêutica, medicamento composto e kit | |
JP2013518051A5 (es) | ||
ES2422286T3 (es) | Uso de apamina para tratar la enfermedad de Parkinson |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |